FDA Okays Another Extended-Release Topiramate for Epilepsy FDA Okays Another Extended-Release Topiramate for Epilepsy

FDA has approved another once-daily extended-release formulation of topiramate (Qudexy XR), this one for children as young as 2 years and in the form of capsules that can be opened and the contents sprinkled on food. FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news